Preclinical studies have demonstrated MSC-EVs are capable of effectively regenerating pancreatic beta-cell mass, ameliorating autoimmune reaction, restoring insulin production, and preventing disease onset in T1DM murine models [19,20,21]. The gene discussed is INS; the disease is type 1 diabetes mellitus.